1cP-MiPLA Blotters – 200mcg

Introduction

1cP‑MiPLA Blotters – 200mcg are a 1cP‑MiPLA (1‑cyclopropionyl‑N‑methyl‑N‑isopropyl‑lysergamide) research chemical delivered in standardized blotter‑paper format, with each small square labeled at 200mcg to support consistent, low‑mass dosing in analytical and research‑oriented experiments. Blotter‑based carriers are widely used in laboratory settings for studying lysergamide distribution, uniformity, and extraction behavior, and this 200mcg format is particularly suited to laboratories that require clearly defined, easily handled units for tightly controlled, non‑clinical work. This product is supplied exclusively for research‑grade lysergamide applications and is not intended for any use involving human or animal ingestion, treatment, or diagnostic procedures.

Scientific Overview

1cP‑MiPLA (1‑cyclopropionyl‑N‑methyl‑N‑isopropyl‑lysergamide, CAS 3028950‑74‑2 or closely related identifiers) is a semisynthetic lysergamide analog of LSD and MiPLA, in which the lysergamide core is modified by a cyclopropionyl group at the nitrogen‑1 position and a distinctive N‑methyl‑N‑isopropylamide substitution, yielding a structurally complex lysergamide scaffold of interest to pharmacological research. Within the scientific literature, lysergamides of this class are typically characterized for their physicochemical properties, chromatographic profile, and receptor‑binding behavior under strictly controlled, non‑clinical conditions, with no reference to subjective human‑experience data. 1cP‑MiPLA Blotters – 200mcg are supplied strictly as a laboratory‑grade lysergamide reference substance and must not be used for diagnostic, therapeutic, or consumer‑oriented purposes.

Product Specifications

• Product Name: 1cP‑MiPLA Blotters – 200mcg.

• Chemical Name: 1‑Cyclopropionyl‑N‑methyl‑N‑isopropyl‑lysergamide (often referred to by its synonym 1‑cyclopropionyl‑lysergic acid N,N‑methylisopropylamide).

• CAS Number: 3028950‑74‑2 (or 2028950‑74‑2, depending on supplier convention).

• IUPAC Name: (8β)‑1‑(cyclopropylcarbonyl)‑9,10‑didehydro‑N,6‑dimethyl‑N‑(1‑methylethyl)‑ergoline‑8‑carboxamide.

• Molecular Formula: C₂₄H₂₉N₃O₂.

• Molecular Weight: Approximately 454.5 g/mol.

• Compound Class: Novel lysergamide research chemical.

• Form: Blotter‑paper squares (laboratory‑grade blotter substrate).

• Dosage per Unit: 200mcg per blotter.

• Purity: Typically ≥ 97–99% research‑grade, where verified by analytical methods such as HPLC, GC‑MS, NMR, or LC‑MS, with trace impurities kept below established laboratory thresholds.

• Physical Properties: The pure compound is typically a white‑to‑off‑white amorphous or crystalline solid, supplied pre‑impregnated into thin blotter paper.

• Solubility: Generally soluble in common organic solvents such as ethanol, methanol, acetonitrile, and DMSO, but exhibits limited solubility in water, supporting controlled extraction into solution for chromatographic or receptor‑binding studies.

• Appearance: Uniform small blotter‑paper squares with clear grid‑like markings and consistent print quality.

• Quantity: Available in labeled packs (e.g., 5, 10, 25, 50, 100 blotters), enabling repeated use across multiple assay runs and experimental conditions.

• Storage Conditions: Store in a cool, dry, light‑resistant, low‑humidity environment inside sealed, moisture‑resistant, and light‑blocking packaging; refrigeration at 2–8°C is recommended to help preserve the lysergamide on blotter paper and minimize degradation over time.

Laboratory Use Context

1cP‑MiPLA Blotters – 200mcg are intended exclusively for in‑vitro, analytical, and non‑clinical research, including lysergamide stability and decomposition testing on cellulose‑based blotter carriers, controlled extraction experiments, chromatographic method development, and forensic or reference‑material work involving N1‑cyclopropionyl‑N‑methyl‑N‑isopropyl‑substituted lysergamides. The blotter format supports reproducible mass loading, uniform compound distribution, and straightforward documentation of sample preparation steps, making it especially useful for laboratories focused on quantitative profiling, receptor‑binding studies, or method‑validation projects under strict research‑oriented frameworks. This product must not be used in any human or animal‑focused therapeutic, preventive, or diagnostic context and is reserved solely for lawful, laboratory‑based experimentation conducted by qualified personnel following standard laboratory‑safety practices.

Quality & Testing

To support rigorous, reproducible science, each batch of 1cP‑MiPLA Blotters – 200mcg is accompanied by COA‑based documentation, including batch number, purity estimates, retention‑time data, and a summary of the analytical methods used for characterization where available. Multi‑method verification such as chromatographic profiling, spectrometric analysis, and additional physicochemical tests helps define the material’s profile and reinforces traceability, supporting E‑E‑A‑T‑aligned sourcing for research institutions and analytical laboratories. Clear labeling and batch‑specific records are designed to give laboratories confidence that each blotter unit is consistent, well‑defined, and suitable for tightly controlled experimental work involving lysergamide reference standards.

Shipping & Handling

Orders are discreetly packaged in neutral, light‑resistant, and moisture‑resistant, often foil‑or pouch‑sealed materials to help maintain the integrity of the lysergamide‑laden blotter paper during transit. Discreet worldwide shipping is offered where permitted by local regulations, with batch‑aware handling and tracking features that support secure delivery and logistical transparency. Packaging is designed to minimize exposure to heat, humidity, and physical shocks, further supporting the stability of the material and ensuring that each blotter square remains intact, uncontaminated, and chemically sound upon arrival at the laboratory.

Compliance Disclaimer

For Research Use Only. Not for human consumption.
This product is not intended to diagnose, treat, cure, or prevent any disease and must not be used in any human or animal therapeutic context. 1cP‑MiPLA Blotters – 200mcg are strictly reserved for lawful laboratory or analytical research conducted by qualified personnel in accordance with applicable local, national, and international regulations. The legal status of 1cP‑MiPLA and related lysergamides varies significantly by jurisdiction, and it is the responsibility of the purchaser to verify compliance with all relevant laws before ordering, receiving, storing, or handling this material.